CLINICAL_TRIALS
trial_result
· 2018-10-22
Clinical Trial Update: A Pharmacokinetic Study on the Effect of LY2216684 on the Active Metabolite of Clopidogrel [Phase 1]
Summary
Phase 1 pharmacokinetic study assessing the effect of LY2216684 on the active metabolite of clopidogrel; completed with results posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Major Depressive Disorder | Phase 1 | Status: COMPLETED | Results posted: 2018-10-22